Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Insulin changes sex hormone levels in women with polycystic ovary syndrome without affecting other hormone releases.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Antiandrogen therapy is effective and well tolerated for treating women's androgenic disorders like hirsutism, acne, and hair loss.

A rare ovarian tumor caused high testosterone in a postmenopausal woman, resolved by surgery.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

BMI is not enough for assessing obesity in women; use more personalized tools.

A young woman's rare ovarian tumor was successfully removed, improving her hormonal symptoms.

The conclusion is that sex-verification in sports was harmful and changes have been made to address this.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Ethnicity affects how polycystic ovary syndrome shows up in women, with white women having higher metabolic risks but less diabetes, and South Asian women showing more androgenic symptoms and being younger at presentation.

Losing weight, possibly through bariatric surgery, is key to improving PCOS and hyperandrogenism symptoms in obese patients.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Women are more likely to have long-term post-COVID symptoms than men.

Hair restoration surgery for women is improving with better techniques and understanding.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The document concludes that hirsutism in women, often caused by PCOS, requires systematic evaluation and can be treated with medications, mechanical removal, or cosmetic methods, with weight loss also being beneficial.

Oral contraceptives are effective for treating hyperandrogenism, while ovarian electrocautery is better for women with infertility.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

Polycystic ovarian disease symptoms can continue after menopause, making diagnosis and management in older women challenging.

Hair transplantation helps women with hair loss; understanding and empathy lead to happy patients.

Ovarian wedge resection helped regulate menstrual cycles but didn't significantly change hormone levels or hair growth in polycystic ovary syndrome.